150 related articles for article (PubMed ID: 7719931)
1. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
Printz M; Reynolds J; Mento SJ; Jolly D; Kowal K; Sajjadi N
Gene Ther; 1995 Mar; 2(2):143-50. PubMed ID: 7719931
[TBL] [Abstract][Full Text] [Related]
2. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.
Reeves L; Duffy L; Koop S; Fyffe J; Cornetta K
Hum Gene Ther; 2002 Sep; 13(14):1783-90. PubMed ID: 12396630
[TBL] [Abstract][Full Text] [Related]
3. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
Chen J; Reeves L; Sanburn N; Croop J; Williams DA; Cornetta K
Virology; 2001 Mar; 282(1):186-97. PubMed ID: 11259201
[TBL] [Abstract][Full Text] [Related]
4. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
[TBL] [Abstract][Full Text] [Related]
5. An improved method for detection of replication-competent retrovirus in retrovirus vector products.
Uchida E; Sato K; Iwata A; Ishii-Watabe A; Mizuguchi H; Hikata M; Murata M; Yamaguchi T; Hayakawa T
Biologicals; 2004 Sep; 32(3):139-46. PubMed ID: 15536044
[TBL] [Abstract][Full Text] [Related]
6. Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors.
Lamers CH; Willemsen RA; van Elzakker PM; Gratama JW; Debets R
J Immunother; 2009 Apr; 32(3):272-9. PubMed ID: 19242373
[TBL] [Abstract][Full Text] [Related]
7. Detection of replication competent retrovirus and lentivirus.
Sastry L; Cornetta K
Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
[TBL] [Abstract][Full Text] [Related]
8. [Bio-safety testing for retroviral vector as gene therapy delivery system].
Zhu M; Dai Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):48-50. PubMed ID: 12759953
[TBL] [Abstract][Full Text] [Related]
9. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
[TBL] [Abstract][Full Text] [Related]
10. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
11. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
12. Validation of retroviral detection for rodent cell-derived products and gene therapy applications.
Hughes JV; Messner K; Burnham M; Patel D; White EM
Dev Biol Stand; 1996; 88():297-304. PubMed ID: 9119153
[TBL] [Abstract][Full Text] [Related]
13. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production.
Forestell SP; Böhnlein E; Rigg RJ
Gene Ther; 1995 Dec; 2(10):723-30. PubMed ID: 8750011
[TBL] [Abstract][Full Text] [Related]
14. Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors.
Chen J; Reeves L; Cornetta K
Hum Gene Ther; 2001 Jan; 12(1):61-70. PubMed ID: 11177543
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of replication-competent retrovirus.
Forestell SP; Dando JS; Böhnlein E; Rigg RJ
J Virol Methods; 1996 Jul; 60(2):171-8. PubMed ID: 8844623
[TBL] [Abstract][Full Text] [Related]
16. A rapid procedure for screening fibroblast packaging cell lines for secretion of selectable retrovirus.
Elefanty AG; Cory S
Biotechniques; 1993 May; 14(5):770-4. PubMed ID: 8512701
[TBL] [Abstract][Full Text] [Related]
17. PCR and other test systems in human gene therapy.
Morgan RA; Anderson WF
Dev Biol Stand; 1992; 76():171-7. PubMed ID: 1478336
[TBL] [Abstract][Full Text] [Related]
18. Cell line issues related to specific expression vectors: retrovirus vectors.
Morgan EM
Dev Biol Stand; 1992; 76():301-5. PubMed ID: 1478348
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
20. Human primary T lymphocytes have a low capacity to amplify MLV-based amphotropic RCR and the virions produced are largely noninfectious.
Ebeling SB; Simonetti ER; Borst HP; Blok A; Schelen AM; Braakman E; Ederveen J; Hagenbeek A
Gene Ther; 2003 Oct; 10(21):1800-6. PubMed ID: 12960969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
